Tekmira Pharmaceuticals receives $2.4 million grant from National Institutes of Health
Tekmira Pharmaceuticals Corporation, together with collaborators at The University of Texas Medical Branch, has received a $2.4 million worth grant from National Institutes of Health to support research to develop RNAi therapeutics to treat Ebola and Marburg hemorrhagic fever viral infections using Tekmira's lipid nanoparticle delivery technology.
Tetra Tech announced today that it has been awarded a $17 million program for excavation and construction activities associated with the environmental remediation of dioxin contamination at Vietnam's Da Nang Airport.